DarioHealth reports decreased revenue following Twill acquisition

DarioHealth reported a significant decrease in revenue for Q4 2023 compared to the previous year, with a net loss also increasing. The company attributed the decrease in revenue to lower consumer and strategic partner channels. Despite this, DarioHealth’s CEO expressed optimism about the company’s pivot to a new business model, which includes the recent acquisition of Twill, a digital therapeutics company. The acquisition is expected to accelerate the company’s path to profitability and increase pro forma revenues in 2023. DarioHealth’s stock has seen a gradual decrease in value since 2017, but the company is hopeful that its financial profile will continue to improve in the coming year.

Source link

error: Content is protected !!